MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jpag.2008.08.005

Медицинская библиотека · Journal of pediatric and adolescent gynecology · 2009

Effects of pioglitazone on menstrual frequency, hyperandrogenism and insulin resistance in adoloscents and young adults with polycystic ovary syndrome.

Narsing Rao Laddiperla, Jacob Jubbin Jagan, Paul Thomas V, Rajarathinam Simon, Thomas Nihal, Seshadri Mandalam S

Клиническое исследованиеСтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

STUDY

OBJECTIVE

To study the clinical, metabolic and adverse effects of pioglitazone over a period of 6 months in obese adolescent and young adults with polycystic ovary syndrome.

DESIGN

This was an open labeled study. Each patient served as her own control.

SETTING

Outpatient department of a university affiliated teaching hospital.

PARTICIPANTS

Unmarried women (age 15-25 yrs) with chronic anovulatory cycles and obesity, and with clinical evidence of hyperandrogenism.

INTERVENTIONS: Pioglitazone at a dose of 30 mg once daily for a period of 6 months along with dietary advice and exercise.

MAIN OUTCOME MEASURES: Resumption of normal menstrual cycles, clinical improvement in hyperandrogenism and changes in insulin resistance measured by fasting glucose insulin ratios.

RESULTS

Twenty-two women were enrolled. At the end of the study period 91% of the subjects had regularization of menstrual cycles. There was no change in the modified Ferriman-Gallwey hirsutism scores. Decline in fasting insulin levels at the end of the study was 45.6% from baseline along with significant increase in the fasting glucose/insulin ratio from baseline.

CONCLUSION

Administration of pioglitazone for 6 months along with advice about diet and physical activity in obese adolescents and young adult women with polycystic ovary syndrome results in significant improvements in menstrual frequency. There is a significant improvement in insulin resistance using the G/I ratio (<7.5 mg/10(-4) U) as the biochemical marker.

Для цитирования: Narsing Rao Laddiperla, Jacob Jubbin Jagan, Paul Thomas V, Rajarathinam Simon, Thomas Nihal, Seshadri Mandalam S. Effects of pioglitazone on menstrual frequency, hyperandrogenism and insulin resistance in adoloscents and young adults with polycystic ovary syndrome.. Journal of pediatric and adolescent gynecology. 2009. DOI: 10.1016/j.jpag.2008.08.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.